Jaguar Health’s Napo to present results of quality of life survey

Napo Pharmaceuticals announced that the results of “More Than a Diagnosis: A Quality of Life Survey for Individuals with a Diagnosis or History of Cancer,” an online, anonymous Napo-supported survey initiative of Advocates for Collaborative Education to shed light on the diverse and profound challenges faced by individuals living with a diagnosis or a history of cancer, have been accepted for presentation at the December 2023 San Antonio Breast Cancer Symposium. The survey received more than 500 responses and will offer a unique perspective on the experiences and priorities of those affected by cancer. Only the breast cancer related responses will be presented at SABCS, with the remainder of the results to be shared at subsequent oncology symposia and conferences. Advocates for Collaborative Education co-created the survey with patients and survivors to design relevant questions whose answers may help the cancer ecosystem better understand the far-reaching impacts of a cancer diagnosis and treatment on quality of life. The results of this study are poised to transform the way we approach cancer care and support, potentially addressing not only the clinical aspects but also the physical, emotional, social, financial, and psychological impacts on those affected by this relentless disease.